Functional activities of various preparations of human intravenous immunoglobulin against type III group B Streptococcus

Kwang Sik Kim, C. A. Wass, J. H. Kang, B. F. Anthony

Research output: Contribution to journalArticle

Abstract

Two preparations of human immunoglobulin modified for intravenous use (iv immunoglobulin) by different methods (reduction-and-alkylation, or pH 4 treatment) were evaluated for in vitro and in vivo activity against a strain of type III group B Streptococcus (GBS). Both preparations contained similar amounts of total IgG and specific IgG antibody against the type-specific polysaccharide. In vitro, opsonophagocytic studies revealed that pH 4-treated iv immunoglobulin was significantly more effective than reduced-and-alkylated iv immunoglobulin in supporting neutrophil-mediated killing of the type III GBS strain. In vivo, both preparations resulted in similar levels of serum antibody in newborn rats, but pH 4-treated iv immunoglobulin was significantly more protective against the type III GBS strain. This was demonstrated by the lower magnitude of bacteremia, improved survival, and lower protective dose (PD50) in recipients of pH 4-treated iv immunoglobulin. Thus, reduced-and-alkylated iv immunoglobulin was less effective in vitro and in vivo against the strain of type III GBS than was pH 4-treated iv immunoglobulin. Further studies are needed to elucidate the mechanisms for this apparent discrepancy in functional activities of iv immunoglobulin.

Original languageEnglish (US)
Pages (from-to)1092-1097
Number of pages6
JournalJournal of Infectious Diseases
Volume153
Issue number6
StatePublished - 1986
Externally publishedYes

Fingerprint

Streptococcus agalactiae
Intravenous Immunoglobulins
Immunoglobulins
Immunoglobulin G
Antibodies
Alkylation
Bacteremia
Polysaccharides
Neutrophils
Serum

ASJC Scopus subject areas

  • Immunology
  • Public Health, Environmental and Occupational Health

Cite this

Functional activities of various preparations of human intravenous immunoglobulin against type III group B Streptococcus. / Kim, Kwang Sik; Wass, C. A.; Kang, J. H.; Anthony, B. F.

In: Journal of Infectious Diseases, Vol. 153, No. 6, 1986, p. 1092-1097.

Research output: Contribution to journalArticle

@article{92959c0c90cd410983e591e19d5fe8a6,
title = "Functional activities of various preparations of human intravenous immunoglobulin against type III group B Streptococcus",
abstract = "Two preparations of human immunoglobulin modified for intravenous use (iv immunoglobulin) by different methods (reduction-and-alkylation, or pH 4 treatment) were evaluated for in vitro and in vivo activity against a strain of type III group B Streptococcus (GBS). Both preparations contained similar amounts of total IgG and specific IgG antibody against the type-specific polysaccharide. In vitro, opsonophagocytic studies revealed that pH 4-treated iv immunoglobulin was significantly more effective than reduced-and-alkylated iv immunoglobulin in supporting neutrophil-mediated killing of the type III GBS strain. In vivo, both preparations resulted in similar levels of serum antibody in newborn rats, but pH 4-treated iv immunoglobulin was significantly more protective against the type III GBS strain. This was demonstrated by the lower magnitude of bacteremia, improved survival, and lower protective dose (PD50) in recipients of pH 4-treated iv immunoglobulin. Thus, reduced-and-alkylated iv immunoglobulin was less effective in vitro and in vivo against the strain of type III GBS than was pH 4-treated iv immunoglobulin. Further studies are needed to elucidate the mechanisms for this apparent discrepancy in functional activities of iv immunoglobulin.",
author = "Kim, {Kwang Sik} and Wass, {C. A.} and Kang, {J. H.} and Anthony, {B. F.}",
year = "1986",
language = "English (US)",
volume = "153",
pages = "1092--1097",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Functional activities of various preparations of human intravenous immunoglobulin against type III group B Streptococcus

AU - Kim, Kwang Sik

AU - Wass, C. A.

AU - Kang, J. H.

AU - Anthony, B. F.

PY - 1986

Y1 - 1986

N2 - Two preparations of human immunoglobulin modified for intravenous use (iv immunoglobulin) by different methods (reduction-and-alkylation, or pH 4 treatment) were evaluated for in vitro and in vivo activity against a strain of type III group B Streptococcus (GBS). Both preparations contained similar amounts of total IgG and specific IgG antibody against the type-specific polysaccharide. In vitro, opsonophagocytic studies revealed that pH 4-treated iv immunoglobulin was significantly more effective than reduced-and-alkylated iv immunoglobulin in supporting neutrophil-mediated killing of the type III GBS strain. In vivo, both preparations resulted in similar levels of serum antibody in newborn rats, but pH 4-treated iv immunoglobulin was significantly more protective against the type III GBS strain. This was demonstrated by the lower magnitude of bacteremia, improved survival, and lower protective dose (PD50) in recipients of pH 4-treated iv immunoglobulin. Thus, reduced-and-alkylated iv immunoglobulin was less effective in vitro and in vivo against the strain of type III GBS than was pH 4-treated iv immunoglobulin. Further studies are needed to elucidate the mechanisms for this apparent discrepancy in functional activities of iv immunoglobulin.

AB - Two preparations of human immunoglobulin modified for intravenous use (iv immunoglobulin) by different methods (reduction-and-alkylation, or pH 4 treatment) were evaluated for in vitro and in vivo activity against a strain of type III group B Streptococcus (GBS). Both preparations contained similar amounts of total IgG and specific IgG antibody against the type-specific polysaccharide. In vitro, opsonophagocytic studies revealed that pH 4-treated iv immunoglobulin was significantly more effective than reduced-and-alkylated iv immunoglobulin in supporting neutrophil-mediated killing of the type III GBS strain. In vivo, both preparations resulted in similar levels of serum antibody in newborn rats, but pH 4-treated iv immunoglobulin was significantly more protective against the type III GBS strain. This was demonstrated by the lower magnitude of bacteremia, improved survival, and lower protective dose (PD50) in recipients of pH 4-treated iv immunoglobulin. Thus, reduced-and-alkylated iv immunoglobulin was less effective in vitro and in vivo against the strain of type III GBS than was pH 4-treated iv immunoglobulin. Further studies are needed to elucidate the mechanisms for this apparent discrepancy in functional activities of iv immunoglobulin.

UR - http://www.scopus.com/inward/record.url?scp=0022449016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022449016&partnerID=8YFLogxK

M3 - Article

C2 - 3517187

AN - SCOPUS:0022449016

VL - 153

SP - 1092

EP - 1097

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 6

ER -